Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
Author(s): Antonio Greco , Davide Capodanno Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is a valuable treatment option for patients with severe symptomatic aortic stenosis.1 Its use is supported by the results of multiple randomised controlled trials (RCTs) exploring the entire surgical risk spectrum, including inoperable, high-risk, intermediate risk and low risk patients.2–8 TAVI is associated with a small but not negligible… View more

Vascular Disease and Surgery

Intervention
ESC 23: The RIGHT Study
Author(s): Yan Yan , Gilles Montalescot Added: 7 months ago
ESC 23 — Dr Yan Yan (Beijing Anzhen Hospital, CN) and Prof Gilles Montalescot (Pitie Salpetriere APHP University Hospital,FR) discusses the findings from a comparison of anticoagulation prolongation vs no anticoagulation in STEMI patients post-primary PCI (RIGHT) (NCT03664180). The RIGHT study (Beijing Anzhen Hospital) aimed to evaluate the clinical efficacy and safety of anticoagulation… View more

Anticoagulation

MI/ACS
Anticoagulation after PCI in Atrial Fibrillation
Author(s): Christopher P Cannon , Georg Nickenig Added: 5 years ago
Faculty: Professor Christopher Cannon, Harvard Medical School, US Christopher Cannon is a Professor of Medicine at Harvard Medical School, and senior physician in the Cardiovascular Division at Brigham and Women’s Hospital. He earned his MD from Columbia University College of Physicians and Surgeons in New York and completed an internal medicine residency at Columbia Presbyterian Medical… View more

Anticoagulation

Electrophysiology & Arrhythmia
Left Atrial Appendage Occlusion vs. Oral Anticoagulation Therapy with NOAC
Author(s): Jens Erik Nielsen Kudsk , A John Camm , Vivek Reddy Start date: Jul 07, 2020

Anticoagulation

Electrophysiology & Arrhythmia
Antithrombotic Therapy after Percutaneous Coronary Intervention
Author(s): Darshni Arishta Jhagroe , Jur ten Berg Added: 3 years ago
Dual antiplatelet therapy (DAPT) is indicated in patients who need to undergo percutaneous coronary intervention (PCI) procedures.1 Compared with oral anticoagulation (OAC) and aspirin, DAPT has been shown to reduce the risk of thrombotic events and the rate of bleeding events.2 Chronic OAC is required in up to 10 % of the patients undergoing PCI, and is usually indicated for AF and mechanical… View more

Anticoagulation

Intervention
Author(s): Andrew Archbold Added: 3 years ago
Patients who undergo coronary artery stenting require dual antiplatelet therapy (DAPT) in order to reduce their risk of stent thrombosis. Long-term oral anticoagulation (OAC) is indicated for the primary and secondary prevention of thrombotic events in patients with atrial fibrillation (AF), mechanical heart valves, intra-cardiac thrombus, venous thromboembolic disease and some hypercoagulable… View more

Anticoagulation

Prevention & Chronic Conditions
Wrap-up of AHA 2019: An analysis of the late-breaking trials
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 4 years ago
Prof Nicolas Van Mieghem & Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) give their analysis of the late-breaking trials from AHA 2019. View more

Anticoagulation

Standards & Guidelines
View from the Thoraxcenter - What's Hot at AHA 2019
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 4 years ago
Prof Nicolas van Mieghem & Dr Joost Daemen (Erasmus MC, Rotterdam, NL) preview and discuss the late-breaking trials of AHA 2019. View more

Anticoagulation

Heart Failure
Jiminez Rodriguez 2
Author(s): Gian-Manuel Jimenez-Rodriguez Added: 1 year ago
Interventional Cardiology 2023;17:e15. View more

Anticoagulation

Intervention